Suchergebnisse - "Pokrivcak, Tomas"

PubPharm (6)

1

Long-Term Efficacy and Safety of Enzalutamide Monotherapy in Elderly Patients with Metastatic Castration-Resistant Prostate Cancer : A Case Report

enthalten in: Case reports in oncology | 2024

von Pokrivcak, T. | Navratil, J. | Poprach, A. | +2

2

Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1 : outcome, safety, and risk factors for relapse in a population-based study

enthalten in: Therapeutic advances in medical oncology | 2022

von Dieckmann, K. | Pokrivcak, T. | Geczi, L. | +34

3

Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1 : outcome, safety, and risk factors for relapse in a population-based study

enthalten in: Therapeutic advances in medical oncology | March 31, 2022

von Dieckmann, K. | Pokrivcak, T. | Geczi, L. | +34

4

The use of cisplatin in patients after kidney transplantation with chronic renal insufficiency : Is the benefit higher than potential risks in therapy of non-seminomatous germ cell tumors?

enthalten in: Medicine | 2021

von Pokrivcak, T. | Lakomy, R. | Kazda, T. | +3

5

Tyrosine kinase inhibitors in the first-line treatment for metastatic nonclear cell renal carcinoma : A retrospective analysis of a national database

enthalten in: Urologic oncology | 2019

von Poprach, A. | Rumanova, K. | Lakomý, R. | +13

6

Cancer Treatment-induced Changes in Renal Function in Patients with Tumors - Update on Current Knowledge

enthalten in: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti | Winter

von Pokrivčák, T. | Poprach, A.

1
[1]